UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 Current Report


     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

          Date of report (date of earliest event reported): May 8, 2008

                               Balchem Corporation
             (Exact name of registrant as specified in its charter)

Maryland                                   1-13648            13-2578432
(State or other jurisdiction of   (Commission File Number)    (IRS Employer
incorporation)                                               Identification No.)

                      P.O. Box 600, New Hampton, NY 10958
               (Address of principal executive offices)(Zip Code)

       Registrant's telephone number, including area code: (845) 326-5600

         Check the  appropriate  box below if the Form 8-K filing is intended to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:

[_]      Written  communications  pursuant to Rule 425 under the  Securities Act
         (17 CFR 230.425)

[_]      Soliciting  material pursuant to Rule 14a-12 under the Exchange Act (17
         CFR 240.14a-12)

[_]      Pre-commencement  communications  pursuant to Rule  14d-2(b)  under the
         Exchange Act (17 CFR 240.14d-2(b))

[_]      Pre-commencement  communications  pursuant to Rule  13e-4(c)  under the
         Exchange Act (17 CFR 240.13e-4(c))

<PAGE>


Item 2.02 Results of Operations and Financial Condition

On May 8, 2008,  Balchem  Corporation,  reported  earnings for its first quarter
ended March 31, 2008.  The full text of the press  release  issued in connection
with the announcement is attached as Exhibit 99.1.

The  information in this Form 8-K  (including  Exhibit 99.1) shall not be deemed
"filed" for purposes of Section 18 of the  Securities  Exchange Act of 1934 (the
"Exchange  Act") or otherwise  subject to the  liabilities of that section,  nor
shall it be deemed  incorporated by reference in any filing under the Securities
Act of 1933 or the  Exchange  Act,  except as  expressly  set forth by  specific
reference in such a filing.

Item 9.01 Financial Statements and Exhibits

(c) Exhibits.

99.1      Press Release of Balchem Corporation, dated May 8, 2008, reporting its
financial results for the first quarter of 2008.


<PAGE>

                                    SIGNATURE

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                            BALCHEM CORPORATION


                                            By:/s/ Francis J. Fitzpatrick
                                            ------------------------------------
                                            Francis J. Fitzpatrick
                                            Chief Financial Officer

Dated: May 9, 2008


<PAGE>


                                  Exhibit Index


Exhibit Number                     Description
--------------                     -----------


99.1           Press Release of Balchem Corporation, dated May 8, 2008